Cross priming of naïve CD8 T cells by professional APC invokes a program leading to tumor specific-cytotoxic T lymphocytes (CTL) which proliferate and traffic to the tumor site where they ultimately attack and destroy tumor cells [3]. The gene discussed is CD8A; the disease is neoplasm.